| Lipids Management |
1 |
1 |
| PCSK9 |
0 |
0.95 |
| Cardiovascular Risk Management |
0 |
0.66 |
| LDL Cholesterol |
0 |
0.99 |
| Adherence |
0 |
0.3 |
| Revenue and Practice Management |
0 |
0.23 |
| Drug Costs |
0 |
0.2 |
| Liver |
0 |
0.15 |
| Coronary Artery Disease (CAD) |
0 |
0.11 |
| Blood |
0 |
0.1 |
| Face |
0 |
0.1 |
| Financial Reimbursement |
0 |
0.1 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Insurance |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| Statins |
0 |
0.1 |
| Familial Hypercholesterolemia |
0 |
0.07 |
| Hemoglobin A1c |
0 |
0.07 |
| Cardiovascular disease |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Colorado |
0 |
0.05 |
| Diet |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Hemoglobin |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Hypercholesterolemia |
0 |
0.05 |
| Jobs |
0 |
0.05 |
| Medical Life |
0 |
0.05 |
| Pandemic |
0 |
0.05 |
| Travel Medicine |
0 |
0.05 |